Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Clinical trial NCT06536868 · RECRUITING
Trial details
- NCT number
- NCT06536868
- Sponsor
- Second Hospital of Shanxi Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.